Notify me when KAHN BROTHERS GROUP INC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 53 | $564,703,786 | +$1,821,974 | -$19,558,638 | -$17,736,664 | C, BAYRY, FLG, MRK, DIS | 13F-HR | 12 Feb 2026, 10:57 |
| Q3 2025 | 53 | $531,799,267 | +$48,018,981 | -$47,427,202 | +$591,779 | C, BAYRY, FLG, DIS, OGN | 13F-HR | 12 Nov 2025, 11:09 |
| Q2 2025 | 51 | $497,799,476 | +$55,007,227 | -$53,178,462 | +$1,828,765 | C, BAYRY, DIS, FLG, MRK | 13F-HR | 14 Aug 2025, 15:07 |
| Q1 2025 | 54 | $494,450,436 | +$42,154,038 | -$26,879,944 | +$15,274,094 | C, FLG, MRK, BAYRY, BP | 13F-HR | 15 May 2025, 13:24 |
| Q4 2024 | 51 | $460,360,965 | +$35,946,435 | -$129,105,717 | -$93,159,282 | C, MRK, DIS, BMY, BP | 13F-HR | 14 Feb 2025, 16:05 |
| Q3 2024 | 52 | $580,574,762 | +$28,759,056 | -$144,243,060 | -$115,484,004 | C, MRK, BP, NYCB, BAYRY | 13F-HR | 13 Nov 2024, 11:41 |
| Q2 2024 | 51 | $594,639,762 | +$54,021,368 | -$71,205,786 | -$17,184,418 | C, MRK, BP, GSK, NYCB | 13F-HR | 14 Aug 2024, 15:14 |
| Q1 2024 | 52 | $674,361,970 | +$59,407,307 | -$24,505,175 | +$34,902,132 | AGO, MRK, C, BP, GSK | 13F-HR | 15 May 2024, 14:14 |
| Q4 2023 | 42 | $634,758,663 | +$6,995,276 | -$19,419,873 | -$12,424,597 | AGO, MRK, NYCB, C, BP | 13F-HR | 13 Feb 2024, 10:33 |
| Q3 2023 | 43 | $640,877,891 | +$3,628,599 | -$13,366,541 | -$9,737,942 | NYCB, BP, MRK, AGO, PTEN | 13F-HR | 13 Nov 2023, 16:42 |
| Q2 2023 | 43 | $681,883,509 | +$2,385,908 | -$23,628,454 | -$21,242,546 | MRK, NYCB, BP, BMY, AGO | 13F-HR | 09 Aug 2023, 14:59 |
| Q1 2023 | 45 | $694,716,732 | +$8,082,890 | -$27,017,077 | -$18,934,187 | BP, MRK, BMY, NYCB, AGO | 13F-HR | 12 May 2023, 10:36 |
| Q4 2022 | 45 | $759,627,946 | +$3,977,852 | -$8,766,966 | -$4,789,114 | AGO, MRK, BP, PTEN, BMY | 13F-HR | 15 Feb 2023, 10:56 |
| Q3 2022 | 45 | $641,738,075 | +$14,172,176 | -$13,580,854 | +$591,322 | BMY, BP, AGO, MRK, PTEN | 13F-HR | 15 Nov 2022, 10:02 |
| Q2 2022 | 45 | $742,713,150 | +$21,143,320 | -$17,714,736 | +$3,428,584 | PTEN, AGO, BMY, MRK, BP | 13F-HR | 10 Aug 2022, 12:36 |
| Q1 2022 | 46 | $787,553,692 | +$141,574,938 | -$152,540,309 | -$10,965,371 | PTEN, AGO, MBI, BMY, BP | 13F-HR | 02 May 2022, 14:12 |
| Q4 2021 | 43 | $726,583,929 | +$17,294,913 | -$1,886,854 | +$15,408,059 | MBI, AGO, GSK, PFE, BP | 13F-HR | 25 Jan 2022, 09:25 |
| Q3 2021 | 43 | $710,349,072 | +$22,098,909 | -$6,842,961 | +$15,255,948 | AGO, MBI, BP, NYCB, C | 13F-HR | 01 Nov 2021, 10:31 |
| Q2 2021 | 43 | $698,337,400 | +$26,898,067 | -$48,320,381 | -$21,422,314 | AGO, C, BMY, PTEN, BP | 13F-HR | 04 Aug 2021, 10:17 |
| Q1 2021 | 42 | $646,072,714 | +$5,498,915 | -$58,980,316 | -$53,481,401 | AGO, C, NYCB, MERCK, BMY | 13F-HR | 07 May 2021, 14:09 |
| Q4 2020 | 42 | $573,282,964 | +$3,735,569 | -$53,696,935 | -$49,961,366 | MERCK, BMY, C, AGO, GSK | 13F-HR | 11 Feb 2021, 10:45 |
| Q3 2020 | 42 | $527,501,198 | +$6,618,271 | -$45,361,177 | -$38,742,906 | MERCK, BMY, GSK, NYCB, C | 13F-HR | 06 Nov 2020, 09:36 |
| Q2 2020 | 47 | $591,789,869 | +$18,151,504 | -$25,376,216 | -$7,224,712 | MERCK, GSK, BMY, NYCB, C | 13F-HR | 03 Aug 2020, 14:43 |
| Q1 2020 | 48 | $546,731,759 | +$1,746,549 | -$25,637,784 | -$23,891,235 | MERCK, GSK, BMY, NYCB, BP | 13F-HR | 11 May 2020, 10:16 |
| Q4 2019 | 47 | $824,383,022 | +$2,046,384 | -$24,593,217 | -$22,546,833 | MERCK, C, AGO, GSK, BMY | 13F-HR | 27 Jan 2020, 13:41 |
| Q3 2019 | 48 | $707,124,324 | +$14,851,093 | -$11,881,222 | +$2,969,871 | C, AGO, NYCB, GSK, BP | Restatement | 05 Nov 2019, 10:40 |
| Q2 2019 | 44 | $710,394,822 | +$168,777,644 | -$7,636,426 | +$161,141,218 | C, BP, AGO, GSK, SEB | 13F-HR | 05 Aug 2019, 11:27 |
| Q1 2019 | 32 | $640,039,482 | +$25,190,055 | -$43,699,662 | -$18,509,607 | MERCK, BP, C, AGO, GSK | 13F-HR | 06 May 2019, 10:06 |
| Q4 2018 | 31 | $554,659,017 | +$7,987,495 | -$12,454,463 | -$4,466,968 | MERCK, BP, C, AGO, GSK | 13F-HR | 29 Jan 2019, 14:33 |
| Q3 2018 | 31 | $651,154,836 | +$14,791,074 | -$16,946,998 | -$2,155,924 | C, BP, MERCK, AGO, BB | 13F-HR | 30 Oct 2018, 14:36 |
| Q2 2018 | 31 | $628,427,841 | +$12,405,431 | -$16,586,420 | -$4,180,989 | BP, C, MERCK, GSK, NYT | 13F-HR | 06 Aug 2018, 10:09 |
| Q1 2018 | 31 | $627,749,630 | +$16,024,147 | -$26,958,600 | -$10,934,453 | C, BP, NYT, BB, MERCK | 13F-HR | 01 May 2018, 15:04 |
| Q4 2017 | 31 | $636,583,328 | +$16,689,533 | -$16,808,552 | -$119,019 | C, BP, NYT, MERCK, BB | 13F-HR | 25 Jan 2018, 14:34 |
| Q3 2017 | 34 | $638,703,838 | +$24,581,055 | -$40,372,208 | -$15,791,153 | C, NYT, MERCK, BP, BB | Restatement | 07 Nov 2017, 12:21 |
| Q2 2017 | 34 | $655,750,110 | +$24,683,317 | -$28,557,241 | -$3,873,924 | C, NYT, MERCK, BP, GSK | 13F-HR | 08 Aug 2017, 11:52 |
| Q1 2017 | 35 | $579,907,285 | +$27,691,717 | -$28,674,731 | -$983,014 | C, MERCK, NYT, BP, GSK | 13F-HR | 08 May 2017, 13:58 |
| Q4 2016 | 35 | $592,097,735 | +$32,718,355 | -$45,687,223 | -$12,968,868 | C, MERCK, NYT, BP, HOLX | 13F-HR | 31 Jan 2017, 14:23 |
| Q3 2016 | 35 | $552,085,961 | +$15,942,765 | -$17,175,595 | -$1,232,830 | MERCK, C, HOLX, BP, NYT | 13F-HR | 01 Nov 2016, 10:03 |
| Q2 2016 | 37 | $516,560,861 | +$11,602,265 | -$29,269,972 | -$17,667,707 | MERCK, C, NYT, BP, HOLX | 13F-HR | 09 Aug 2016, 13:27 |
| Q1 2016 | 37 | $533,881,988 | +$9,214,291 | -$19,788,513 | -$10,574,222 | MERCK, NYT, C, HOLX, NYCB | 13F-HR | 09 May 2016, 10:58 |
| Q4 2015 | 38 | $559,658,866 | +$9,663,435 | -$6,829,012 | +$2,834,423 | C, MERCK, NYT, HOLX, PFE | 13F-HR | 08 Feb 2016, 10:02 |
| Q3 2015 | 38 | $540,186,470 | +$20,453,645 | -$19,099,017 | +$1,354,628 | C, HOLX, PFE, NYCB, MERCK | 13F-HR | 09 Nov 2015, 12:11 |
| Q2 2015 | 40 | $593,047,215 | +$17,875,961 | -$27,292,911 | -$9,416,950 | C, PFE, MERCK, NYCB, NYT | 13F-HR | 28 Jul 2015, 10:12 |
| Q1 2015 | 42 | $592,070,302 | +$8,133,219 | -$33,266,902 | -$25,133,683 | PFE, MERCK, C, NYT, NYCB | 13F-HR | 06 May 2015, 09:33 |
| Q4 2014 | 44 | $568,378,460 | +$8,547,948 | -$40,287,954 | -$31,740,006 | C, MERCK, PFE, NYT, NYCB | 13F-HR | 03 Feb 2015, 10:54 |
| Q3 2014 | 44 | $614,806,574 | +$3,696,317 | -$38,827,765 | -$35,131,448 | MERCK, C, PFE, NYCB, NYT | 13F-HR | 06 Nov 2014, 10:45 |
| Q2 2014 | 43 | $687,327,107 | +$67,805,152 | -$51,107,274 | +$16,697,878 | NYT, C, MERCK, PFE, NYCB | 13F-HR | 06 Aug 2014, 14:37 |
| Q1 2014 | 42 | $700,505,354 | +$93,631,061 | -$4,579,862 | +$89,051,199 | NYT, PFE, MERCK, NYCB, C | 13F-HR | 07 May 2014, 13:56 |
| Q4 2013 | 42 | $550,755,673 | $0 | $0 | $0 | NYT, PFE, C, NYCB, ORI | 13F-HR | 04 Feb 2014, 13:44 |